Business ❯ Finance ❯ Investments

Biotechnology

Clinical Trials Psychedelics Corporate Governance Agenus Inc. Biogen Inc Mergers and Acquisitions Sarepta Therapeutics Asset Management Avidity Biosciences Market Analysis Alnylam Pharmaceuticals Cystic Fibrosis Intellia Therapeutics Omeros Gene Editing Biotech Stocks Aptose Biosciences CRISPR Therapeutics Bavarian Nordic

Skye Bioscience Investors Pressed to Seek Lead Role After Class Action Filing

Plaintiffs' firms are mobilizing after Skye’s October trial update drove a 60% one-day stock plunge.

Cathie Wood’s ARK Buys $24 Million of CoreWeave After Guidance Cut

MoonLake Investors Get Deadline Reminder as Securities Suits Mount Over Sonelokimab Trial

ARK Invest Trims Tesla, AMD as It Adds Circle, BitMine and Bullish in Multi‑Day Shift

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in SDNY Securities Case

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug